Literature DB >> 26760818

Livedoid vasculopathy: fast involution after anticoagulant and hyperbaric oxygen therapy.

Patricia Weinschenker Bollmann1, Andréa Kazumi Shimada2, Nilceo Schwery Michalany3, Ana Rita de Araújo Burgos Manhani4, Auro Del Giglio2.   

Abstract

The livedoid vasculopathy is a rare condition characterized by the presence of recurrent painful ulcers in distal extremities of lower limbs. Histologically there is thickness of dermal vessels, occlusion of its light by fibrin thrombi associated with minimal inflammatory infiltrate. It might occur as an isolated condition or be associated with an underlying systemic disease, including coagulation and collagen disorders, or neoplasms. Because it is a rare disease there is no consensus for its treatment. We report a case of a 41-year-old man with painful ulcers in the lower extremities. We did not find any associated diseases. The lesions improved dramatically after treatment with anticoagulant and hyperbaric therapy. We concluded that anticoagulation associated with hyperbaric oxygenation may be benefit for the treatment of patients with livedoid vasculopathy. However, further studies should be done with a larger population to confirm our results.

Entities:  

Year:  2011        PMID: 26760818     DOI: 10.1590/S1679-45082011RC1676

Source DB:  PubMed          Journal:  Einstein (Sao Paulo)        ISSN: 1679-4508


  3 in total

Review 1.  Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Authors:  Asli Bilgic; Salih Ozcobanoglu; Burcin Cansu Bozca; Erkan Alpsoy
Journal:  Int J Womens Dermatol       Date:  2021-09-02

2.  Livedoid Vasculopathy: diagnosis and treatment in pregnant women.

Authors:  Alexandre Sacchetti Bezerra; Accácio de Almeida Abussamra Junqueira de Andrade; Afonso César Polimanti; Rafael Vilhena de Carvalho Fürst; Paulo Ricardo Criado; João Antônio Corrêa
Journal:  J Vasc Bras       Date:  2020-06-01

Review 3.  From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy.

Authors:  Paulo Ricardo Criado; Hélio Amante Miot; Thais Prota Hussein Pincelli; Alexandre Todorovic Fabro
Journal:  Dermatol Ther       Date:  2020-11-30       Impact factor: 3.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.